Elastic Band Resistance Training and liver disease in Postmenopausal Women

Effect of Elastic Band Resistance Training on irisin, liver enzymes, Hepatic Steatosis and Metabolic Outcomes in Postmenopausal Women with MASLD

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241205063953N4

Enrollment

Registered

2026-01-19

Start date

2026-01-25

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver diseases. Nonalcoholic steatohepatitis (NASH)

Interventions

Intervention 1: Intervention group: Elastic band resistance training group. This group practiced elastic band resistance training under the supervision of instructors for 8weeks, 3 sessions per week,

Eligibility

Sex/Gender

Female

Age

55 Years to 75 Years

Inclusion criteria

Inclusion criteria: Body mass index between 40 and 50 kg/m² Stable body weight (±3%) during the preceding three months No engagement in structured exercise training within the previous six months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hepatic Steatosis. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: Method for quantifying liver fat content (CAP).;ALT. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: ALT levels were measured using a commercial kit (Pars Azmoon, Tehran, Iran) with enzymatic methods.;AST. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: AST levels were measured using a commercial kit (Pars Azmoon, Tehran, Iran) with enzymatic methods.;Irisin. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: Measured using the enzyme-linked immunosorbent assay (ELISA) method with an enzyme immunoassay kit (Phoenix Pharmaceuticals®, Burlingame, USA).;Insulin. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: Insulin levels were measured using the enzyme-linked immunosorbent assay (ELISA) method and equipment (ZellBio, Ulm, Germany).;Glucose. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: Glucose levels were measured using a commercial kit (Pars Azmoon, Tehran, Iran) with photometric and enzymatic methods.	—

Measure

Time frame

Hepatic Steatosis. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: Method for quantifying liver fat content (CAP).;ALT. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: ALT levels were measured using a commercial kit (Pars Azmoon, Tehran, Iran) with enzymatic methods.;AST. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: AST levels were measured using a commercial kit (Pars Azmoon, Tehran, Iran) with enzymatic methods.;Irisin. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: Measured using the enzyme-linked immunosorbent assay (ELISA) method with an enzyme immunoassay kit (Phoenix Pharmaceuticals®, Burlingame, USA).;Insulin. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: Insulin levels were measured using the enzyme-linked immunosorbent assay (ELISA) method and equipment (ZellBio, Ulm, Germany).;Glucose. Timepoint: 48 hours before and after 8 weeks of research. Method of measurement: Glucose levels were measured using a commercial kit (Pars Azmoon, Tehran, Iran) with photometric and enzymatic methods.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contact?Akram Jafari

Islamic Azad University

Jafari.akm@gmail.com+98 912 547 9267

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026